IQE plc (AIM: IQE) signals recovery with strong H2 2025 momentum and Q1 2026 order book strength amid strategic review

IQE plc (AIM: IQE) reported a stronger-than-expected finish to 2025, driven by accelerated U.S. military program funding, resurgent AI and data center demand, and handset-linked wireless gains out of Taiwan. The compound semiconductor specialist now expects full-year 2025 revenues to reach approximately £97 million, with adjusted EBITDA of at least £2.0 million, at the upper end of guidance. The company also confirmed it is in negotiations over multiple strategic alternatives, including full and partial asset sales.

The update comes at a critical inflection point for the Cardiff-headquartered wafer manufacturer, which has been navigating liquidity challenges and working capital constraints for much of the past year. A covenant waiver granted by HSBC Bank plc for Q4 2025 further underscores the delicate balance between recovery and restructuring as IQE prepares to reframe its future in 2026.

How did IQE achieve its surprise upside in H2 2025, and why was military demand a key trigger?

The late-stage surge in IQE plc’s 2025 performance was fueled primarily by the early release of U.S. government funds earmarked for defense-related semiconductor programs. These disbursements, initially forecast for 2026, brought forward demand for IQE’s advanced wafer products across sensing and communications modules embedded in aerospace and defense platforms.

This uptick was compounded by higher-than-expected orders for photonics devices powering AI workloads and optical transceivers in hyperscale data centers. IQE also benefited from a lift in wireless product demand linked to late-cycle handset launches, which gave a boost to its Taiwan operations. The combined effect pushed the company to the upper end of its revenue forecast, restoring some operational leverage as underutilized capacity began to fill.

While revenue at approximately £97 million marks a modest recovery in absolute terms, the real significance lies in the adjusted EBITDA rebound to at least £2.0 million—a shift from break-even territory that signals the first tangible proof point that IQE’s restructuring efforts and cost control are gaining traction.

What are the implications of IQE’s strategic review and potential asset sale negotiations?

IQE plc’s board disclosed that it is actively negotiating non-binding offers not only for the group in its entirety, but also for standalone assets or business units. While no transaction is guaranteed, the breadth of interest suggests that IQE’s intellectual property, manufacturing footprint, and long-term customer relationships retain value, even if the group remains under strategic stress.

The strategic review signals both a willingness and a necessity to consider structural change. At a minimum, this could include asset-level divestitures to shore up liquidity or accelerate focus on higher-growth verticals like photonics. At the more ambitious end, a complete sale to an industrial buyer or financial sponsor could provide a pathway for deeper investment and scale consolidation in an increasingly capital-intensive semiconductor landscape.

Importantly, the language of “intrinsic value recognition” suggests that suitors may see IQE’s assets as undervalued, especially in a market where Western semiconductor supply chain security is driving premium valuations for compound semiconductors with military and AI relevance.

How is IQE positioned across core end markets entering 2026?

IQE plc begins 2026 with a notably improved Q1 order book, providing rare forward visibility across key verticals: consumer mobile, data center infrastructure, and AI-enabled photonics. The wireless recovery, observed during Q4 2025, is expected to persist into early 2026 on the back of recent design wins and long-term customer relationships.

Photonics remains the most strategically important segment in terms of long-term differentiation. Demand for optoelectronic devices used in AI inferencing, optical networking, and edge processing continues to build as hyperscalers deploy next-generation data center architectures. IQE’s manufacturing capabilities in this domain, coupled with its IP portfolio, give it a potentially defendable position—though competitors such as II-VI Incorporated (now Coherent Corp.) and Tower Semiconductor remain formidable.

In wireless, while growth is more cyclical and tied to device refresh cycles, the Taiwan division’s performance hints at incremental margin recovery opportunities if utilization improves. That said, IQE’s mobile exposure also represents execution risk should handset volumes plateau or OEM platform transitions move away from compound semiconductors.

Why did IQE require a covenant waiver, and what does this say about liquidity outlook?

IQE’s disclosure of a covenant waiver from HSBC Bank plc for Q4 2025 indicates that without the waiver, the company may have risked technical breach due to low EBITDA generation earlier in the year. The waiver itself is positioned as a sign of trust and alignment with its lending partner, but it also reinforces that IQE is not yet out of the woods financially.

The company reported a cash balance of £15.6 million as of 31 December 2025, reflecting some success in renegotiating terms with suppliers and customers to alleviate near-term working capital pressures. Nonetheless, the relatively thin cash buffer leaves little room for shocks or extended downturns, making the outcome of the strategic review increasingly consequential.

This fragility explains why the board is keeping multiple restructuring pathways open and maintaining optionality across potential acquirers or capital partners.

What are the second-order implications for compound semiconductor markets and European players?

IQE plc’s rebound comes at a time when the compound semiconductor sector is gaining renewed strategic significance across defense, telecom, and AI verticals. Gallium arsenide (GaAs) and indium phosphide (InP) wafers—core to IQE’s portfolio—are increasingly viewed as foundational to next-generation radar, lidar, and optical communication systems.

European policymakers have also identified compound semiconductors as a frontier technology class deserving of industrial policy support under the broader push for supply chain sovereignty. Any acquisition of IQE by a non-European player could attract scrutiny under UK and EU national security regimes, especially given the company’s role in supplying high-spec wafers for defense contractors and photonics integrators.

If IQE’s asset base is ultimately sold in parts, it may signal a broader industry shift toward specialization, where wafer fabs double down on narrow verticals rather than attempting full-stack capability across markets. Alternatively, a successful recapitalization or acquisition could reboot IQE’s long-term role as a UK-based strategic supplier in a sector where domestic capabilities are becoming a geopolitical priority.

What are the key execution risks for IQE as it seeks to stabilize?

Despite signs of operational improvement, IQE’s outlook remains highly contingent on a handful of interlocking variables: the successful completion of a strategic transaction, continued demand strength across its niche markets, and the ability to sustain working capital improvements without eroding supply chain trust.

The company’s relatively small size in a capital-heavy sector creates a scale disadvantage that is only partially mitigated by its IP and engineering capabilities. Any disruption in defense funding cycles, handset demand softness, or delays in AI-related photonics deployment could unwind the progress achieved in late 2025.

Moreover, the strategic review itself may become a distraction or source of uncertainty if prolonged. Customers evaluating long-term supply agreements may delay commitments until ownership clarity emerges, making momentum fragile unless stabilized quickly.

Will investors begin re-rating IQE plc stock if strategic clarity emerges in early 2026?

Investor sentiment toward IQE plc has been cautious but watchful. While the trading update points to better fundamentals, the stock remains under pressure from its longer-term underperformance and capital structure concerns. The Q1 2026 order book, if confirmed in the next earnings update, could serve as a confidence signal. But re-rating will likely hinge on tangible outcomes from the strategic review process.

If a full sale or partial asset transaction materializes—particularly one that provides capital injection or strengthens technological alignment—market perception could shift toward a recovery narrative. Absent that, investors may remain skeptical until recurring profitability and strategic focus are firmly re-established.

Key takeaways on what IQE plc’s trading update and strategic review mean for investors, customers, and the semiconductor sector

• IQE plc expects FY25 revenue of approximately £97 million, with adjusted EBITDA reaching at least £2.0 million.
• The company beat expectations on the back of early U.S. defense contract releases and strong photonics and handset-linked wireless demand.
• A Q4 2025 EBITDA covenant waiver from HSBC underscores the fragile but improving liquidity position.
• A robust Q1 2026 order book points to improving demand visibility across mobile, AI, and data center verticals.
• The board is in negotiations for both full-company and asset-level transactions under its strategic review.
• Suitor interest signals external belief in IQE’s IP and photonics capabilities despite capital structure constraints.
• Execution risks remain tied to working capital sustainability, end-market volatility, and transaction timing.
• Strategic alternatives could attract regulatory scrutiny if foreign ownership of defense-linked assets is proposed.
• If no deal materializes, IQE may need to raise funds or continue operational restructuring independently.
• The company’s trajectory in 2026 will serve as a bellwether for the viability of mid-cap compound semiconductor firms in an increasingly consolidated ecosystem.